Get more replies from employers
Send a job-specific resume in minutes.
Tempus AI, Inc. in Chicago is seeking an Associates level BD professional to support the business development team in securing partnerships with biopharma and academic accounts.
You will draft client proposals, coordinate across teams, and help execute go-to-market activities while building relationships and tracking KPIs. The role offers a pathway to growth within a fast-moving life sciences tech firm.
The Associates level in CHI: $70,000 - $85,000
The expected salary range may vary for other locations. Actual salary may vary based on qualifications and experience.
Tempus offers a full range of benefits, which may include incentive compensation, restricted stock units, medical and other benefits depending on the position.
We are an equal opportunity employer. We do not discriminate on the basis of race, religion, color, national origin, gender, sexual orientation, age, marital status, veteran status, or disability status.
Tempus was founded in August of 2015 by Eric Lefkofsky, after his wife was diagnosed with Breast Cancer. Shortly after he founded the company in an effort to bring the power of technology and artificial intelligence to cancer care, he convinced Ryan Fukushima to join as the company’s first employee. Ryan and Eric began assembling a world class team, focused on building the first version of a platform capable of ingesting real time healthcare data in an effort to personalize diagnostics. We built the platform for oncology and have expanded it to neuropsychiatry, cardiology, infectious disease (through COVID), and radiology. Despite our rapid growth, our mission remains the same—to help make sure patients are on the right drug at the right time, so they can live longer and healthier lives. We’re looking for people who can change the world. Who question the status quo and don’t shy away from tough problems. For the builders who are never done building and the learners who are never done learning. We’re looking for passionate people with undying curiosity. Those who want to attack one of the most challenging problems mankind has ever faced. Head on.